Viewing Study NCT07353827

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-29 @ 11:55 PM
Study NCT ID: NCT07353827
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-01-20
First Post: 2026-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intrahepatic Cholangiocarcinoma (Icc) View
None Hepatic Arterial Infusion Chemotherapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Unresectable liver cancer View
None Hepatic arterial infusion chemotherapy View
None Oxaliplatin-based chemotherapy View
None Immune checkpoint inhibitor therapy View
None Targeted anti-angiogenic therapy View
None Phase II clinical trial View